VKTX 8-K 2026-09-22

Viking Therapeutics, Inc. (VKTX) 8-K dated 2026-09-22 — accession 0001193125-26-397219. This URL is the filing, not the VKTX hub.

Viking Therapeutics, Inc. (VKTX) is a biotechnology company listed on US.

Viking Therapeutics, Inc. filed a 8-K on 2026-09-22. Accession 0001193125-26-397219.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VKTX revenue for 2025-12-31 was $0. Net income was -$359.6M. VKTX currently screens at market cap $3.97B.

Not investment advice. The VKTX SEC hub lists recent forms. The stock page is the research view.